KEDM.com on X
Myriad Genetics $MYGN has seen insiders (ao the CEO) add shares for the first time in quite some time. Always interesting to check out. With ~70% GMs there should be plenty of room to improve profitability at this life science and diagnostics company, and 2026 seems to be the year.
